Global Information
회사소개 | 문의 | 비교리스트

세계의 심장 모니터링(CM) 및 심장박동관리(CRM) 기기 시장 예측(-2024년) : 심전도(ECG), 이식형 루프 기록계(ILR), 이벤트 모니터, MCT

Cardiac Monitoring & Cardiac Rhythm Management Devices Market CM (ECG, ILR, Event Monitors, MCT), CRM (Defibrillator (ICD (CRT D), External Defibrillators (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User (Hospitals) - Global Forecast to 2024

리서치사 MarketsandMarkets
발행일 2019년 10월 상품 코드 263650
페이지 정보 영문 185 Pages
가격
US $ 4,950 ₩ 5,922,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,956,000 PDF by E-mail (5-user license) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,750,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,964,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 심장 모니터링(CM) 및 심장박동관리(CRM) 기기 시장 예측(-2024년) : 심전도(ECG), 이식형 루프 기록계(ILR), 이벤트 모니터, MCT Cardiac Monitoring & Cardiac Rhythm Management Devices Market CM (ECG, ILR, Event Monitors, MCT), CRM (Defibrillator (ICD (CRT D), External Defibrillators (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User (Hospitals) - Global Forecast to 2024
발행일 : 2019년 10월 페이지 정보 : 영문 185 Pages

심장 모니터링(CM) 및 심장박동관리(CRM) 기기 시장은 2019년 207억 달러에서 2024년까지 250억 달러에 달할 것으로 예측됩니다. 2019-2024년간 연평균 복합 성장률(CAGR) 3.9%의 성장이 예측됩니다.

세계의 심장 모니터링(CM: Cardiac Monitoring) 및 심장박동관리(CRM : Cardiac Rhythm Management) 기기 시장에 대해 조사 분석했으며, 시장 개요, 산업 동향, 부문별 시장 분석, 경쟁 상황, 주요 기업 등에 대해 체계적인 정보를 제공합니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

  • 심장 모니터링(CM) 및 심장박동관리(CRM) 기기 : 시장 개요
  • 아시아태평양 - 심장 모니터링(CM) 및 심장박동관리(CRM) 기기 시장 점유율 : 최종사용자별, 국가별
  • 심장박동관리(CRM) 기기 시장 : 종류별
  • 심장 모니터링(CM) 및 심장박동관리(CRM) 기기 시장 지역별 현황

제5장 시장 개요

  • 서론
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 해결해야 할 과제

제6장 심장 모니터링(CM) 기기 시장 : 종류별

  • 서론
  • 심전도(ECG)
    • 안정시 심전도
    • 부하 심전도
    • 홀터 심전계
  • 이식형 루프 레코더(ILR)
  • 모바일 심장 원격 측정법(MCT) 기기
  • 심박출량 모니터링(COM) 기기
  • 이벤트 모니터
  • 스마트 웨어러블 심전도(ECG) 모니터

제7장 심장박동관리(CRM) 기기 시장 : 종류별

  • 서론
  • 제세동기
  • 페이스 메이커

제8장 심장 모니터링(CM) 및 심장박동관리(CRM) 기기 시장 : 최종사용자별

  • 서론
  • 병원, 클리닉, 심장센터
  • ASC
  • 기타

제9장 심장 모니터링(CM) 및 심장박동관리(CRM) 기기 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 기타

제10장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 경쟁 시나리오
  • 경쟁 리더십 매핑

제11장 기업 개요

  • ABBOTT LABORATORIES
  • MEDTRONIC, PLC
  • BOSTON SCIENTIFIC CORPORATION
  • GE HEALTHCARE
  • KONINKLIJKE PHILIPS N.V.
  • BIOTRONIK
  • ASAHI KASEI CORPORATION
  • MICROPORT SCIENTIFIC CORPORATION
  • HILL-ROM HOLDINGS
  • NIHON KOHDEN CORPORATION
  • SCHILLER
  • BIOTELEMETRY
  • ACS DIAGNOSTICS
  • BPL MEDICAL TECHNOLOGIES
  • BTL
  • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • LEPU MEDICAL TECHNOLOGY
  • SHREE PACETRONIX
  • OSYPKA AG
  • ALIVECOR, INC.

제12장 부록

LSH 19.11.08

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

LIST OF TABLES

  • TABLE 1 RECENT PRODUCT INNOVATIONS IN THE CM & CRM MARKET
  • TABLE 2 KEY PRODUCT RECALLS
  • TABLE 3 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 4 ECG DEVICES & EVENT MONITORS MARKET, 2017-2024 (UNITS)
  • TABLE 5 ECG DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 6 ECG DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7 NORTH AMERICA: ECG DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 8 EUROPE: ECG DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 9 APAC: ECG DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 10 RESTING ECG DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11 STRESS ECG DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12 HOLTER MONITORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14 NORTH AMERICA: IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 15 EUROPE: IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 16 APAC: IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 17 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18 TYPES OF COM DEVICES
  • TABLE 19 CARDIAC OUTPUT MONITORING DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20 NORTH AMERICA: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 21 EUROPE: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 22 APAC: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 23 EVENT MONITORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24 NORTH AMERICA: EVENT MONITORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 25 EUROPE: EVENT MONITORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 26 APAC: EVENT MONITORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 27 EVENT MONITORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 28 PRE-SYMPTOM EVENT MONITORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29 POST-SYMPTOM EVENT MONITORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30 INDICATIVE LIST OF SMART ECG MONITORS
  • TABLE 31 SMART ECG MONITORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 33 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (UNITS)
  • TABLE 34 DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 35 DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024(USD MILLION)
  • TABLE 37 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 38 APAC: DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 39 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 40 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 41 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024(USD MILLION)
  • TABLE 42 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 43 APAC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 44 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 45 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 46 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 47 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 48 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 49 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 50 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 51 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 52 INDICATIVE LIST OF AEDS THAT HAVE RECEIVED PREMARKET APPROVAL FROM THE FDA (2018-2019)
  • TABLE 53 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 54 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 55 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 56 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 57 PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 58 NORTH AMERICA: PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 59 EUROPE: PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 60 APAC: PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 61 PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024(USD MILLION)
  • TABLE 62 IMPLANTABLE PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 63 NORTH AMERICA: IMPLANTABLE PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 64 EUROPE: IMPLANTABLE PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 65 APAC: IMPLANTABLE PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 66 EXTERNAL PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 67 NORTH AMERICA: EXTERNAL PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 68 EUROPE: EXTERNAL PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 69 APAC: EXTERNAL PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 70 PACEMAKERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 71 DUAL-CHAMBER PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 72 SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 73 BIVENTRICULAR/CRT PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 74 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 75 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, CLINICS, & CARDIAC CENTERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 76 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, CLINICS, & CARDIAC CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 77 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, CLINICS, & CARDIAC CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 78 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, CLINICS, & CARDIAC CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 79 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 80 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 81 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 82 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 83 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 84 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 85 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 86 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 87 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 88 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 89 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 90 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 91 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 92 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 93 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 94 NORTH AMERICA: ECG DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 95 NORTH AMERICA: EVENT MONITORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 96 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 97 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 99 NORTH AMERICA: T-ICDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 100 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 101 NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 102 NORTH AMERICA: PACEMAKERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 103 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 104 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 105 US: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 106 US: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 107 US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 108 US: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 109 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 110 CANADA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 111 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 112 CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 113 CANADA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 114 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 115 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 116 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 117 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 118 EUROPE: ECG DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 119 EUROPE: EVENT MONITORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 120 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 121 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 122 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 123 EUROPE: T-ICDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 124 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 125 EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 126 EUROPE: PACEMAKERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 127 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 128 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 129 GERMANY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 130 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 131 GERMANY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 132 GERMANY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 133 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 134 FRANCE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 135 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 136 FRANCE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 137 FRANCE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 138 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 139 UK: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 140 UK: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 141 UK: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 142 UK: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 143 ITALY: NUMBER OF ELDERLY CITIZENS WITH ATRIAL FIBRILLATION (IN THOUSANDS)
  • TABLE 144 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 145 ITALY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 146 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 147 ITALY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 148 ITALY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 149 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 150 SPAIN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 151 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 152 SPAIN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 153 SPAIN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 154 ROE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 155 ROE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 156 ROE: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 157 ROE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 158 ROE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 159 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 160 APAC: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 161 APAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 162 APAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 163 APAC: ECG DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 164 APAC: EVENT MONITORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 165 APAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 166 APAC: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 167 APAC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 168 APAC: T-ICDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 169 APAC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 170 APAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 171 APAC: PACEMAKERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 172 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 173 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 174 JAPAN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 175 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 176 JAPAN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 177 JAPAN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 178 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 179 CHINA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 180 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 181 CHINA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 182 CHINA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 183 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 184 INDIA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 185 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 186 INDIA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 187 INDIA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 188 ROAPAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 189 ROAPAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 190 ROAPAC DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 191 ROAPAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 192 ROAPAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 193 ROW: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 194 ROW: ECG DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 195 ROW: EVENT MONITORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 196 ROW: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 197 ROW: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 198 ROW: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 199 ROW: T-ICDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 200 ROW: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 201 ROW: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 202 ROW: PACEMAKERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 203 ROW: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4 MARKET SIZE ESTIMATION: CRM DEVICES MARKET
  • FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 6 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 7 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2019 VS. 2024
  • FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
  • FIGURE 10 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES WILL DRIVE MARKET GROWTH
  • FIGURE 11 HOSPITALS, CLINICS, & CARDIAC CENTERS DOMINATED THE CM & CRM DEVICES MARKET IN THE APAC IN 2018
  • FIGURE 12 DEFIBRILLATORS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 14 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 15 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 16 FRANCE: CRM DEVICE IMPLANTATION, 2015-2018
  • FIGURE 17 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 18 JAPAN: HEALTH EXPENDITURE AS A SHARE OF GDP, 2005-2016
  • FIGURE 19 CRM DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018
  • FIGURE 20 MNM VENDOR DIVE COMPARISON MATRIX: CM & CRM DEVICES MARKET
  • FIGURE 21 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018)
  • FIGURE 22 MEDTRONIC: COMPANY SNAPSHOT (2018)
  • FIGURE 23 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2018)
  • FIGURE 24 GE HEALTHCARE: COMPANY SNAPSHOT (2018)
  • FIGURE 25 PHILIPS: COMPANY SNAPSHOT (2018)
  • FIGURE 26 ASAHI KASEI: COMPANY SNAPSHOT (2018)
  • FIGURE 27 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 28 HILL-ROM HOLDINGS: COMPANY SNAPSHOT (2018)
  • FIGURE 29 NIHON KOHDEN: COMPANY SNAPSHOT (2018)
  • FIGURE 30 BIOTELEMETRY: COMPANY SNAPSHOT (2018)
  • FIGURE 31 LEPU MEDICAL: COMPANY SNAPSHOT (2016)
  • FIGURE 32 SHREE PACETRONIX: COMPANY SNAPSHOT (2018)

"Increasing prevalence of CVD to drive the growth of this market."

The cardiac monitoring and cardiac rhythm management devices market is projected to reach USD 25.0 billion by 2024 from USD 20.7 billion in 2019, at a CAGR of 3.9%. Growth in this market is primarily driven by the increasing incidence of cardiovascular diseases; technological advancements; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices. However, the dearth of skilled professionals and frequent product recalls are expected to challenge market growth in the coming years

"ILRs are expected to grow at the highest CAGR during the forecast period."

Based on type, the CM devices market is segmented into ECG devices, ILR, MCT, event monitors, COM devices, and smart ECG monitors. Of these, ILRs are expected to grow at the highest CAGR during the forecast period. The advantages of ILRs are a higher rate of diagnosis of heart rhythm problems than external recorders, long-term monitoring of up to three years, large storage capacity, remote monitoring, and detection & reduction of recurrent syncopes. Owing to their benefits, the demand for these devices is expected to increase across the globe

"The defibrillators segment is expected to grow at the highest CAGR during the forecast period."

Based on type, the CRM devices market is segmented into defibrillators and pacemakers. The defibrillators segment is expected to grow at the highest CAGR in the forecast period. Technological advancements in defibrillators, rising prevalence of CVDs, and the growing focus on providing public-access defibrillators are some of the major factors expected to propel the growth of this market.

"The ambulatory surgical centers segment is expected to grow at the highest CAGR during the forecast period."

The ambulatory surgical centers segment is expected to grow at the highest CAGR in the forecast period. Growing number of ASCs and physicians are realizing the benefits of performing cardiovascular procedures at ASCs, thus attributing to its high CAGR during the forecast period.

"APAC to grow at the highest CAGR during the forecast period."

In the CM & CRM devices market, the APAC market, particularly in China, Japan, India, and the Association of Southeast Asian Nations (ASEAN) countries, is expected to witness the highest growth in the next five years. This is due to the rising prevalence of CVDs in APAC countries, attributed to the increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the CM & CRM devices market.

  • By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
  • By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
  • By Region: North America: 50%, Europe: 20%, APAC: 15%, and RoW: 15%

The CM & CRM devices market comprises major players such as Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), Hill-Rom Holdings (US), and Koninklijke Philips (Netherlands). The study includes an in-depth competitive analysis of these key players in the CM & CRM devices market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the CM & CRM devices market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, based on CM devices by type, and based on CRM devices by type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall CM & CRM devices market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKETS COVERED
  • 1.4 YEARS CONSIDERED FOR THE STUDY
  • 1.5 CURRENCY
  • 1.6 LIMITATIONS
  • 1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 SECONDARY DATA
    • 2.2.1 KEY DATA FROM SECONDARY SOURCES
  • 2.3 PRIMARY DATA
    • 2.3.1 KEY DATA FROM PRIMARY SOURCES
  • 2.4 MARKET SIZE ESTIMATION
    • 2.4.1 REVENUE MAPPING-BASED MARKET ESTIMATION
  • 2.5 DATA TRIANGULATION
    • 2.5.1 ASSUMPTIONS FOR THE STUDY
    • 2.5.2 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES: MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SHARE, BY END USER & COUNTRY (2018)
  • 4.3 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE (2017-2024)
  • 4.4 GEOGRAPHIC SNAPSHOT OF THE CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS: DRIVERS, RESTRAINTS, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of cardiovascular disease
      • 5.2.1.2 Technological advancements
      • 5.2.1.3 Increasing investments, funds, and grants for research on CM & CRM devices
      • 5.2.1.4 Growing preference for wearable cardiac devices
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increasing incidence of CIED infections
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Dearth of skilled professionals with expertise in electrocardiography and cardiac rhythm management devices
      • 5.2.3.2 Frequent product recalls

6 CARDIAC MONITORING DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 ECG DEVICES
    • 6.2.1 RESTING ECG DEVICES
      • 6.2.1.1 Low cost, ease of use, and simplicity have driven the adoption of resting ECG devices
    • 6.2.2 STRESS ECG DEVICES
      • 6.2.2.1 Flexibility in use has driven the demand for stress ECG devices, but high cost has negatively affected the market
    • 6.2.3 HOLTER MONITORS
      • 6.2.3.1 Short duration of monitoring is a key restraint to market growth
  • 6.3 IMPLANTABLE LOOP RECORDERS
    • 6.3.1 HIGH COST AND LIMITED APPLICATIONS HAVE HINDERED DEMAND GROWTH
  • 6.4 MOBILE CARDIAC TELEMETRY DEVICES
    • 6.4.1 INCREASING DEMAND FOR CARDIAC MONITORING SOLUTIONS IN HOME CARE SETTINGS IS PROPELLING MARKET GROWTH
  • 6.5 CARDIAC OUTPUT MONITORING DEVICES
    • 6.5.1 INCREASING NUMBER OF CARDIAC SURGERIES WILL DRIVE THE DEMAND FOR COM DEVICES
  • 6.6 EVENT MONITORS
    • 6.6.1 EVENT MONITORS MARKET, BY TYPE
      • 6.6.1.1 Pre-symptom event monitors
        • 6.6.1.1.1 Large storage capacity of pre-symptom event monitors makes them ideal for long-term monitoring
      • 6.6.1.2 Post-symptom event monitors
        • 6.6.1.2.1 Emergence of handheld, wireless, and remote monitors will drive market growth
    • 6.6.2 EVENT MONITORS MARKET, BY TECHNOLOGY
      • 6.6.2.1 Autodetect monitors
        • 6.6.2.1.1 Autodetect monitors are ideal for patients who are unable to reliably trigger monitors
      • 6.6.2.2 Manual event monitors
        • 6.6.2.2.1 Manual monitors can be pre-symptom or post-symptom, but rely on the patient to be triggered
  • 6.7 SMART ECG MONITORS
    • 6.7.1 LACK OF DATA SECURITY HINDERS THE GROWTH OF THE SMART MONITORS MARKET TO SOME EXTENT

7 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 DEFIBRILLATORS
    • 7.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
      • 7.2.1.1 Transvenous implantable cardioverter defibrillators (T-ICDs)
        • 7.2.1.1.1 Biventricular implantable cardioverter defibrillators/cardiac resynchronization therapy defibrillators
        • 7.2.1.1.1.1 Biventricular ICDs/CRT-Ds are preferred for heart failure patients
        • 7.2.1.1.2 Dual-chamber implantable cardioverter defibrillators
        • 7.2.1.1.2.1 Benefits of dual-chamber ICDs, such as higher diagnostic accuracy, make them ideal for patients with tachycardia episodes
        • 7.2.1.1.3 Single-chamber implantable cardioverter defibrillators
        • 7.2.1.1.3.1 Launch of MRI-compatible single-chamber ICDs will drive market growth
      • 7.2.1.2 Subcutaneous implantable cardioverter defibrillators
        • 7.2.1.2.1 Safety and efficacy of S-ICDs in the prevention of sudden cardiac arrest will boost their adoption
    • 7.2.2 EXTERNAL DEFIBRILLATORS
      • 7.2.2.1 Automated external defibrillators
        • 7.2.2.1.1 Semi-automated external defibrillators
        • 7.2.2.1.1.1 Semi-automated external defibrillators accounted for the largest share of the AEDs market in 2018
        • 7.2.2.1.2 Fully automated external defibrillators
        • 7.2.2.1.2.1 Benefits of fully automatic AEDs and higher accuracy will drive market growth
      • 7.2.2.2 Manual external defibrillators
        • 7.2.2.2.1 North America dominates the manual defibrillators market
      • 7.2.2.3 Wearable cardioverter defibrillators
        • 7.2.2.3.1 Ease of use and the noninvasive nature of wearable cardioverter defibrillators will support market growth
  • 7.3 PACEMAKERS
    • 7.3.1 PACEMAKERS MARKET, BY IMPLANTABILITY
      • 7.3.1.1 Implantable pacemakers
        • 7.3.1.1.1 Introduction of leadless and MRI-safe devices has boosted device popularity
      • 7.3.1.2 External pacemakers
        • 7.3.1.2.1 Increasing number of open-heart surgeries will drive the demand for external pacemakers
    • 7.3.2 PACEMAKERS MARKET, BY TYPE
      • 7.3.2.1 Dual-chamber pacemakers
        • 7.3.2.1.1 Dual-chamber pacemakers are the most commonly implanted pacemakers for bradycardia-a key factor driving market growth
      • 7.3.2.2 Single-chamber pacemakers
        • 7.3.2.2.1 Introduction of leadless pacemakers will stimulate demand in this product segment
      • 7.3.2.3 Biventricular/CRT pacemakers
        • 7.3.2.3.1 High cost and unfavorable reimbursement scenario have hindered market growth

8 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS, CLINICS, & CARDIAC CENTERS
    • 8.2.1 GROWING NUMBER OF CARDIAC IMPLANT PROCEDURES TO DRIVE MARKET GROWTH
  • 8.3 AMBULATORY SURGERY CENTERS
    • 8.3.1 GROWING NUMBER OF ASCS IN THE US TO DRIVE THE ADOPTION OF CM & CRM DEVICES
  • 8.4 OTHER END USERS

9 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 Growing number of FDA approvals for CM & CRM devices to support market growth in the US
    • 9.2.2 CANADA
      • 9.2.2.1 Growing focus of government and private organizations on providing funding for research to drive market growth
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Increasing healthcare expenditure to drive market growth
    • 9.3.2 FRANCE
      • 9.3.2.1 Rising prevalence of heart failure to drive the adoption of CRT devices in France
    • 9.3.3 UK
      • 9.3.3.1 Rising demand for home-based cardiac monitoring devices to support market growth
    • 9.3.4 ITALY
      • 9.3.4.1 Increasing incidence of atrial fibrillation among the elderly will drive market growth in Italy
    • 9.3.5 SPAIN
      • 9.3.5.1 Rising awareness and growing device adoption indicate strong growth in the coming years
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 JAPAN
      • 9.4.1.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan
    • 9.4.2 CHINA
      • 9.4.2.1 Rising prevalence of CVDs and government support for infrastructural improvements will drive market growth
    • 9.4.3 INDIA
      • 9.4.3.1 Government initiatives will propel market growth in India
    • 9.4.4 REST OF ASIA PACIFIC
  • 9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET SHARE ANALYSIS, 2018
  • 10.3 COMPETITIVE SCENARIO
    • 10.3.1 CONTRACTS, PARTNERSHIPS, & AGREEMENTS (2016-2019)
    • 10.3.2 PRODUCT LAUNCHES & APPROVALS (2016-2019)
    • 10.3.3 EXPANSIONS (2016-2019)
    • 10.3.4 ACQUISITIONS (2016-2019)
  • 10.4 COMPETITIVE LEADERSHIP MAPPING (2019)
    • 10.4.1 VENDOR INCLUSION CRITERIA
    • 10.4.2 VISIONARY LEADERS
    • 10.4.3 DYNAMIC DIFFERENTIATORS
    • 10.4.4 EMERGING COMPANIES

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 11.1 ABBOTT LABORATORIES
  • 11.2 MEDTRONIC, PLC
  • 11.3 BOSTON SCIENTIFIC CORPORATION
  • 11.4 GE HEALTHCARE
  • 11.5 KONINKLIJKE PHILIPS N.V.
  • 11.6 BIOTRONIK
  • 11.7 ASAHI KASEI CORPORATION
  • 11.8 MICROPORT SCIENTIFIC CORPORATION
  • 11.9 HILL-ROM HOLDINGS
  • 11.10 NIHON KOHDEN CORPORATION
  • 11.11 SCHILLER
  • 11.12 BIOTELEMETRY
  • 11.13 ACS DIAGNOSTICS
  • 11.14 BPL MEDICAL TECHNOLOGIES
  • 11.15 BTL
  • 11.16 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • 11.17 LEPU MEDICAL TECHNOLOGY
  • 11.18 SHREE PACETRONIX
  • 11.19 OSYPKA AG
  • 11.20 ALIVECOR, INC.

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
Back to Top
전화 문의
F A Q